Total raised
—
Stage
Pre-Seed
Founded
2019
Headcount
3
HQ
Tel Aviv-Yafo
Sector
Health Tech & Life Sciences
About
Fibplant is developing a genetically engineered Fibrinogen, intended to be uses as a biological glue for an existing pharma drug market.
The company's advanced active compositions are based on therapeutic proteins produced in transgenic plants, and made for Surgery and Emergency medicine.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsHerbals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
Verified
Tags
biological-therapymolecular-biologydrug-developmentplant-genomicslife-sciencesgenetic-engineeringbioprocessbiopharmaceuticalpharmaceuticalsplant-proteinbiotechnologysurgery